Skip to main content
. 2022 Feb 21;15(8):1534–1541. doi: 10.1093/ckj/sfac048

Table 1.

Patient characteristics at index admission according to suPAR level

Characterisitcs All patients (N = 5124) suPAR <3 ng/mL [n = 2738 (53.4%)] suPAR 3–6 ng/mL [n = 1945 (38.0%)] suPAR ≥6 ng/mL [n = 441 (8.6%)]
Demographics
 Female, n (%) 2612 (51.0) 1365 (49.9) 1031 (53.0) 216 (49.0)
 Age (years), median (IQR) 65.9 (50.5–76.9) 59.1 (44.4–72.0) 71.1 (58.6–80.4) 71.4 (60.5–81.7)
Biomarkers
 suPAR (ng/mL), median (IQR) 2.9 (2.2–4.1) 2.2 (1.8–2.6) 3.9 (3.4–4.6) 7.6 (6.7–9.6)
 eGFR (mL/min/1.73 m2), median (IQR) 88.0 (75.3–102) 92.2 (80.0–106) 83.1 (71.3–96.8) 80.9 (68.9–97.1)
 CRP (mg/L), median (IQR) 6.0 (2.0–28) 3.0 (1.0–10) 11 (3.0–49) 31 (7.0–81)
 Sodium (mEq/L), median (IQR) 139 (136–141) 139 (137–141) 138 (135–140) 136 (132–139)
Chronic disease status, n (%)
 Diabetes 796 (15.5) 326 (11.9) 381 (19.6) 89 (20.2)
 Hypertension 1782 (34.8) 804 (29.4) 792 (40.7) 186 (42.2)
 Cardiovascular disease 1533 (29.9) 726 (26.5) 657 (33.8) 150 (34.0)
Outcomes
 Length of stay (days), median (IQR) 0.9 (0.4–3.9) 0.7 (0.3–2.1) 1.4 (0.5–5.1) 2.6 (0.8–7.8)
 Time to readmission (days), median (IQR) 144 (35–378) 170 (41–417) 128 (32–338) 84 (23–262)